Pharma and the Changing US Payer Environment: Meeting the demands of Accountable Care Organizations (ACOs)
[Published by FirstWord Pharma]
Published by FirstWord Pharma: 01 Nov 2013 | 81 | In Stock
There’s a revolution happening...and it’s going to change the way pharma thinks.
As the accountable care movement gains traction in the United States and physicians eye a possible trillion in saved healthcare costs, ACOs are emerging quickly. There is no question that knitting together improved quality of care, real world data and quality measures will result in lower healthcare expenditures. But how will that affect pharma?
The answer lies in being a first-mover, understanding what it takes to be a successful ACO and most of all, adjusting traditional marketing and development practices in response. To be agile in the face of revolution, pharma must first understand the complete scope of the change now underway.
In Pharma and the Changing US Payer Environment: Meeting the demands of Accountable Care Organizations (ACOs), FirstWord explores the rapidly changing landscape of the accountable care movement and how it is poised to impact pharma. The report examines the types of ACOs, the critical pathway to their success and why it’s so important for pharma to switch marketing and development practices to meet their needs. As an overview of a movement that changes minute-by-minute, the report is an urgently needed snapshot of an industry in transition.
Key Report Features of Pharma and the Changing US Payer Environment: Meeting the demands of Accountable Care Organizations (ACOs) include:
Because accountable care is still evolving, there is an urgent need to stay up to date with changes as they happen. Amongst the many benefits in Pharma and the Changing US Payer Environment: Meeting the demands of Accountable Care Organizations (ACOs), this report will help you to:
Pharma and the Changing US Payer Environment: Meeting the demands of Accountable Care Organizations (ACOs) answers key questions:
The accountable care movement is emerging rapidly. In this report, you will discover:
Table of Contents
for Pharma and the Changing US Payer Environment: Meeting the demands of Accountable Care Organizations (ACOs) [Published by FirstWord Pharma]
2.2.Creating the conditions for assessing value
2.3.PPACA impact on pharma
3.The ACO movement
3.1.1.Enormous potential savings
3.1.2.High cost differentials
3.2.1.Rapid pace of change
3.3.Working with real world data
4.Different kinds of ACO
4.1.Pharmacists enter the fray
4.3.Medicare Shared Savings Programme
4.4.1.Who can take part in an ACO?
4.5.Catering for differences
4.6.1.Choice of risk-sharing deals
5.ACO implications for pharma
5.1.So many variables
5.2.Learning from the pioneers
5.2.2.Other key learnings
5.2.3.Early lessons from the private sector
5.3.Broader dialogue becomes imperative
5.4.New ways of thinking
6.A transitional phase
6.1.Filling the ACO capability gaps
6.3.How can drugs reduce overall costs?
6.4.Information to educate patients
6.5.Optimising medication therapy
6.6.The role of pharmacists in ACOs
6.7.2.Developing a patient focus
6.7.3.Physicians require help
6.8.Patient-centred disease management
6.9.Population health management
7.Learning from the new NHS
8.Issues of trust
9.A marriage of health outcomes and profits
10.Gearing up for change
Number of Pages
|Title||Date Published||Price from||More Details|
|Pharma and the mHealth Revolution - engaging with mobile-enabled physicians and HCPs|
IntroductionIt’s time to click on this.The media’s dubbed them ‘a doctor in your pocket’ and ‘health...
|01 Feb 2013 by FirstWord Pharma||USD $695||More Info|
|Big Data in Pharma Marketing|
IntroductionBig data - the huge volume of digital data generated worldwide - continues to grow expon...
|01 Jan 2013 by FirstWord Pharma||USD $695||More Info|
|Social and Mobile Pharma - the State of the Digital Landscape|
IntroductionTightly-regulated and conservative in outlook, the pharmaceutical industry has largely b...
|01 Nov 2012 by FirstWord Pharma||USD $695||More Info|
|Pharma and Payers – Building Better Relationships|
IntroductionChanges in the healthcare landscape have put payers (public and private) under mounting ...
|01 Sep 2012 by FirstWord Pharma||USD $695||More Info|
|Pharma Reputations: Managing Perceptions|
IntroductionPharma is no stranger to the idea of nurturing and defending corporate reputations. But...
|01 Aug 2012 by FirstWord Pharma||USD $645||More Info|
|Pharma's Future Role in CME|
IntroductionOver the last 10 years, every aspect of continuing medical education (CME) has endured m...
|01 Aug 2012 by FirstWord Pharma||USD $695||More Info|
|Pharma sales force shape, size and structure — where next?|
IntroductionRetarget your sales force with new resourcesSales force management now plays a critical ...
|01 Jul 2012 by FirstWord Pharma||USD $695||More Info|
|Inside China’s Healthcare Reforms: Opportunities for Multinational Pharma|
IntroductionIn 2009, China’s government announced plans to invest RMB1.13 trillion (0 billion) in...
|01 Jun 2012 by FirstWord Pharma||USD $995||More Info|
|Meeting KOL Needs: What Pharma Needs to Know|
IntroductionThe role of the Key Opinion Leader (KOL) has changed over the past 30 years. And it's ab...
|01 Feb 2012 by FirstWord Pharma||USD $1,445||More Info|
|Academic Detailing: Pharma Fights Back|
IntroductionEver since it was introduced three decades ago, academic detailing—which now increasingl...
|01 Jan 2012 by FirstWord Pharma||USD $745||More Info|
This report is published by FirstWord Pharma
Download Free Report Summary PDF
Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.
Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.
Accepted Card Types
Buy now using our secure payment system.